The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin α2-deficient congenital muscular dystrophy

Mutations in the human laminin α2 (LAMA2) gene result in the most common form of congenital muscular dystrophy (MDC1A). There are currently three models for the molecular basis of cellular pathology in MDC1A: (i) lack of LAMA2 leads to sarcolemmal weakness and failure, followed by cellular necrosis, as is the case in Duchenne muscular dystrophy (DMD); (ii) loss of LAMA2-mediated signaling during the development and maintenance of muscle tissue results in myoblast proliferation and fusion defects; (iii) loss of LAMA2 from the basement membrane of the Schwann cells surrounding the peripheral nerves results in a lack of motor stimulation, leading to effective denervation atrophy. Here we show that the degenerative muscle phenotype in the zebrafish dystrophic mutant, candyfloss (caf) results from mutations in the laminin α2 (lama2) gene. In vivo time-lapse analysis of mechanically loaded fibers and membrane permeability assays suggest that, unlike DMD, fiber detachment is not initially associated with sarcolemmal rupture. Early muscle formation and myoblast fusion are normal, indicating that any deficiency in early Lama2 signaling does not lead to muscle pathology. In addition, innervation by the primary motor neurons is unaffected, and fiber detachment stems from muscle contraction, demonstrating that muscle atrophy through lack of motor neuron activity does not contribute to pathology in this system. Using these and other analyses, we present a model of lama2 function where fiber detachment external to the sarcolemma is mechanically induced, and retracted fibers with uncompromised membranes undergo subsequent apoptosis.

[1]  R. Bryson-Richardson,et al.  Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo , 2003, Development.

[2]  K. Matsumura,et al.  Expression of Dystroglycan and the Laminin-α2 Chain in the Rat Peripheral Nerve during Development , 2002, Experimental Neurology.

[3]  M. Ontell,et al.  Transient and chronic neonatal denervation of murine muscle: a procedure to modify the phenotypic expression of muscular dystrophy , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  M. Paulsson,et al.  Laminins: Structure and genetic regulation , 2000, Microscopy research and technique.

[5]  Michael J. Parsons,et al.  Zebrafish mutants identify an essential role for laminins in notochord formation. , 2002, Development.

[6]  R. Burgeson,et al.  Characterization and Expression of the Laminin γ3 Chain: A Novel, Non-Basement Membrane–associated, Laminin Chain , 1999, The Journal of cell biology.

[7]  K. Kawakami Transgenesis and gene trap methods in zebrafish by using the Tol2 transposable element. , 2004, Methods in cell biology.

[8]  P. Laprise,et al.  Merosin‐integrin promotion of skeletal myofiber cell survival: Differentiation state‐distinct involvement of p60Fyn tyrosine kinase and p38α stress‐activated MAP kinase , 2002, Journal of cellular physiology.

[9]  K. Klueber,et al.  Myosatellite cells, growth, and regeneration in murine dystrophic muscle: A quantitative study , 1984, The Anatomical record.

[10]  K. Campbell,et al.  Animal Models for Muscular Dystrophy Show Different Patterns of Sarcolemmal Disruption , 1997, The Journal of cell biology.

[11]  M. Stepp,et al.  Integrins as receptors for laminins , 2000, Microscopy research and technique.

[12]  F. Muntoni,et al.  Evidence of left ventricular dysfunction in children with merosin-deficient congenital muscular dystrophy. , 1998, American heart journal.

[13]  J. Postlethwait,et al.  Radiation hybrid mapping of the zebrafish genome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. North,et al.  The expanding phenotype of laminin α2 chain (merosin) abnormalities: case series and review , 2001, Journal of medical genetics.

[15]  P. Lonai,et al.  Expression and biological role of laminin-1. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[16]  T. Hijikata,et al.  Functional morphology of serially linked skeletal muscle fibers. , 1997, Acta anatomica.

[17]  Michael J. Parsons,et al.  Essential and overlapping roles for laminin α chains in notochord and blood vessel formation , 2006 .

[18]  N. Amizuka,et al.  Zebrafish periostin is required for the adhesion of muscle fiber bundles to the myoseptum and for the differentiation of muscle fibers. , 2004, Developmental biology.

[19]  P. Guicheney,et al.  Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for α2 chain of laminin) , 2002, European Journal of Human Genetics.

[20]  M. Grounds,et al.  Strength at the extracellular matrix–muscle interface , 2005, Scandinavian journal of medicine & science in sports.

[21]  K. Tryggvason,et al.  Structure of the Human Laminin α2-Chain Gene (LAMA2), Which Is Affected in Congenital Muscular Dystrophy* , 1996, The Journal of Biological Chemistry.

[22]  E. Hoffman,et al.  A novel laminin α2 isoform in severe laminin α2 deficient congenital muscular dystrophy , 2000, Neurology.

[23]  C. Leveille,et al.  Molecular Pathogenesis of Muscle Degeneration in the δ-Sarcoglycan-Deficient Hamster , 1998 .

[24]  C. Nüsslein-Volhard,et al.  Neural degeneration mutants in the zebrafish, Danio rerio. , 1996, Development.

[25]  M. Girgenrath,et al.  Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy. , 2004, The Journal of clinical investigation.

[26]  J. Dominov,et al.  Muscle-specific BCL2 expression ameliorates muscle disease in laminin {alpha}2-deficient, but not in dystrophin-deficient, mice. , 2005, Human molecular genetics.

[27]  B. Mokri,et al.  Duchenne dystrophy , 1975, Neurology.

[28]  R. Durbin,et al.  GeneWise and Genomewise. , 2004, Genome research.

[29]  R. Strohman,et al.  Satellite cells from dystrophic (mdx) mouse muscle are stimulated by fibroblast growth factor in vitro. , 1988, Differentiation; research in biological diversity.

[30]  J. D. Porter,et al.  A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. , 2002, Human molecular genetics.

[31]  S. Winder Molecular Mechanisms of Muscular Dystrophies , 2006 .

[32]  D A Kane,et al.  Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva. , 1996, Development.

[33]  C. Angelini,et al.  Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy , 1996, Human Genetics.

[34]  J. Weissenbach,et al.  Mutations in the laminin α2–chain gene (LAMA2) cause merosin–deficient congenital muscular dystrophy , 1995, Nature Genetics.

[35]  Erin L. McDearmon,et al.  Differential Heparin Sensitivity of α-Dystroglycan Binding to Laminins Expressed in Normal and dy/dy Mouse Skeletal Muscle* , 1998, The Journal of Biological Chemistry.

[36]  Michael J. Parsons,et al.  Removal of dystroglycan causes severe muscular dystrophy in zebrafish embryos. , 2002, Development.

[37]  K. Campbell,et al.  Molecular basis of muscular dystrophies , 2000, Muscle & nerve.

[38]  R. Bryson-Richardson,et al.  Myosin heavy chain expression in zebrafish and slow muscle composition , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.